Pharmacologic management of Raynaud's phenomenon.
作者信息
Day T W, Mendoza F
出版信息
South Med J. 1984 Sep;77(9):1160-4. doi: 10.1097/00007611-198409000-00027.
Abstract
Raynaud's phenomenon (RP) represents a wide spectrum of disease activity. Specific pharmacologic therapy, when indicated, should be based upon the clinician's understanding of drug effectiveness and side effects. We present an update of currently available pharmacologic agents being used for RP and review the effectiveness and side effects of these drugs.
摘要
相似文献
1
Pharmacologic management of Raynaud's phenomenon.
South Med J. 1984 Sep;77(9):1160-4. doi: 10.1097/00007611-198409000-00027.
2
Reserpine and Raynaud's phenomenon.
N Engl J Med. 1971 Jul 29;285(5):290-1. doi: 10.1056/NEJM197107292850513.
3
[Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine].
Rev Med Liege. 1980 Oct 1;35(19):652-4.
4
[Spasm and Raynaud's phenomenon].
Ann Cardiol Angeiol (Paris). 1981 Mar-Apr;30(2):91-3.
5
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
Am J Med. 1985 Apr;78(4):602-8. doi: 10.1016/0002-9343(85)90402-4.
6
The diagnosis and treatment of Raynaud's phenomenon.雷诺现象的诊断与治疗。
Surgery. 1975 Jan;77(1):11-23.
7
Raynaud's disease.雷诺氏病
Arch Dis Child. 1985 Jun;60(6):537-41. doi: 10.1136/adc.60.6.537.
8
Raynaud's phenomenon of the nipple: a treatable cause of painful breastfeeding.乳头雷诺现象：母乳喂养疼痛的一个可治疗病因。
Pediatrics. 2004 Apr;113(4):e360-4. doi: 10.1542/peds.113.4.e360.
9
[Pathophysiology and medical treatment of Raynaud's phenomena].
Harefuah. 1973 Feb 15;84(4):227-8.
10
Griseofulvin in Raynaud's phenomenon.
Lancet. 1971 Nov 13;2(7733):1090. doi: 10.1016/s0140-6736(71)90404-1.
Zotero 插件